New MYLUNG Consortium Research Demonstrates Remote Pharmacist Intervention Significantly Increases Clinical Trial Enrollments in Community Oncology Setting
Average monthly enrollment nearly doubled with pharmacy intervention Remote pharmacist easily adapted into clinic workflows in community practices THE WOODLANDS, Texas–(BUSINESS WIRE)–Results from the second phase of the broad, collaborative MYLUNG ConsortiumTM research study in non-small cell lung cancer (NSCLC) were presented by The US Oncology Network (The Network), US Oncology Research and Ontada® at … [Read more…]
